Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.030 |
None |
0.667 |
3 |
|
2012 |
2020 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3926
|
712
|
0.030 |
None |
1.000 |
3 |
|
2015 |
2018 |
Bladder Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2130
|
281
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
862
|
115
|
0.030 |
None |
1.000 |
3 |
|
2007 |
2018 |
Stomach Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3720
|
652
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Childhood Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
771
|
25
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2018 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2346
|
222
|
0.020 |
None |
1.000 |
2 |
|
2004 |
2016 |
Triple Negative Breast Neoplasms
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1674
|
99
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Adult Medulloblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
762
|
24
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2018 |
Triple-Negative Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
1598
|
96
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Malignant neoplasm of stomach
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
3806
|
615
|
0.020 |
None |
1.000 |
2 |
|
2016 |
2018 |
Renal carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
665
|
21
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
HER2-negative breast cancer
|
disease |
|
Neoplastic Process
|
160
|
18
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Malignant neoplasm of thyroid
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
949
|
103
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Central neuroblastoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
2419
|
231
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Cerebellar Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
12
|
5
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Malignant neoplasm of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
508
|
38
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Childhood Neuroblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2420
|
231
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Proliferative Inflammatory Atrophy
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
24
|
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Oestrogen receptor positive breast cancer
|
disease |
|
Neoplastic Process
|
510
|
58
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Luminal A Breast Carcinoma
|
disease |
|
Neoplastic Process
|
153
|
11
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |